
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8951169
[patent_doc_number] => 20130196950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/708558
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21622
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/708558 | Retinoid replacements and opsin agonists and methods for the use thereof | Dec 6, 2012 | Issued |
Array
(
[id] => 9703973
[patent_doc_number] => 08829037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Optical correction'
[patent_app_type] => utility
[patent_app_number] => 13/692257
[patent_app_country] => US
[patent_app_date] => 2012-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3035
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692257
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/692257 | Optical correction | Dec 2, 2012 | Issued |
Array
(
[id] => 8854295
[patent_doc_number] => 20130143970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'MEDICINAL PREPARATION PARTICULARLY FOR THE TREATMENT OF SLIPPED DISCS HERNIAS'
[patent_app_type] => utility
[patent_app_number] => 13/681175
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681175
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/681175 | MEDICINAL PREPARATION PARTICULARLY FOR THE TREATMENT OF SLIPPED DISCS HERNIAS | Nov 18, 2012 | Abandoned |
Array
(
[id] => 9530157
[patent_doc_number] => 08754029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Ophthalmic composition'
[patent_app_type] => utility
[patent_app_number] => 13/678064
[patent_app_country] => US
[patent_app_date] => 2012-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13246
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13678064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/678064 | Ophthalmic composition | Nov 14, 2012 | Issued |
Array
(
[id] => 8780659
[patent_doc_number] => 20130102634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Stabilized and Preserved Ketotifen Ophthalmic Compositions'
[patent_app_type] => utility
[patent_app_number] => 13/673050
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/673050 | Stabilized and Preserved Ketotifen Ophthalmic Compositions | Nov 8, 2012 | Abandoned |
Array
(
[id] => 10451967
[patent_doc_number] => 20150336981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'MODIFIED POLYPHENOLS AND MODIFIED POLYPHENOL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/440402
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 43112
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440402
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440402 | MODIFIED POLYPHENOLS AND MODIFIED POLYPHENOL COMPOSITIONS | Nov 8, 2012 | Abandoned |
Array
(
[id] => 8708665
[patent_doc_number] => 20130065954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'OPHTHALMIC USES OF S1P RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/672027
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5877
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672027
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/672027 | OPHTHALMIC USES OF S1P RECEPTOR MODULATORS | Nov 7, 2012 | Abandoned |
Array
(
[id] => 8697832
[patent_doc_number] => 20130059841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'THERAPEUTIC COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/669318
[patent_app_country] => US
[patent_app_date] => 2012-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19363
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13669318
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/669318 | THERAPEUTIC COMPOSITIONS AND METHODS | Nov 4, 2012 | Abandoned |
Array
(
[id] => 11794058
[patent_doc_number] => 09403808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Pyrazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/658874
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27934
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2021
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658874
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/658874 | Pyrazine derivatives | Oct 23, 2012 | Issued |
Array
(
[id] => 9440234
[patent_doc_number] => 08709342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Antimicrobial flush solutions'
[patent_app_type] => utility
[patent_app_number] => 13/621628
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12439
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621628
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/621628 | Antimicrobial flush solutions | Sep 16, 2012 | Issued |
Array
(
[id] => 8586994
[patent_doc_number] => 20130005815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'AQUEOUS INTRAOCULAR PENETRATION-PROMOTING EYE DROP'
[patent_app_type] => utility
[patent_app_number] => 13/616810
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7937
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/616810 | Aqueous intraocular penetration-promoting eye drop | Sep 13, 2012 | Issued |
Array
(
[id] => 8721226
[patent_doc_number] => 20130072443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'STABILIZED MUTANT OPSIN PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/619238
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10891
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619238
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/619238 | STABILIZED MUTANT OPSIN PROTEINS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8721352
[patent_doc_number] => 20130072569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/619758
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21616
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619758
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/619758 | RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8721344
[patent_doc_number] => 20130072561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/620303
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13387
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620303
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620303 | Methods for the treatment and prevention of age-related retinal dysfunction | Sep 13, 2012 | Issued |
Array
(
[id] => 11176845
[patent_doc_number] => 09408821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Methods for the treatment and prevention of age-related retinal dysfunction'
[patent_app_type] => utility
[patent_app_number] => 13/619947
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 13387
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/619947 | Methods for the treatment and prevention of age-related retinal dysfunction | Sep 13, 2012 | Issued |
Array
(
[id] => 8721341
[patent_doc_number] => 20130072558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/620051
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13390
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620051
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620051 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | Sep 13, 2012 | Abandoned |
Array
(
[id] => 9875423
[patent_doc_number] => 08962691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Retinoid replacements and opsin agonists and methods for the use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/619607
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 21615
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619607
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/619607 | Retinoid replacements and opsin agonists and methods for the use thereof | Sep 13, 2012 | Issued |
Array
(
[id] => 9273127
[patent_doc_number] => 08637054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives'
[patent_app_type] => utility
[patent_app_number] => 13/595165
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5452
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595165 | Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives | Aug 26, 2012 | Issued |
Array
(
[id] => 8523466
[patent_doc_number] => 20120322874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'Pharmaceutical Uses'
[patent_app_type] => utility
[patent_app_number] => 13/593959
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4676
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/593959 | Pharmaceutical Uses | Aug 23, 2012 | Abandoned |
Array
(
[id] => 8841124
[patent_doc_number] => 20130136752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'Ophthalmic Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/588392
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6407
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13588392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/588392 | Ophthalmic Formulations | Aug 16, 2012 | Abandoned |